XML 34 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Cash flows from operating activities:    
Net income (loss) $ 169,590 $ 693,701
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 302,712 278,239
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions 12,087 67,804
Provision for current expected credit losses (3,461) 2,820
Deferred taxes (10,985) (67,345)
Other, net (4,000) (6,012)
Changes in operating assets and liabilities, net of acquisitions:    
Receivables (13,951) (484,287)
Inventories (1,358,021) (716,452)
Accounts payable and accrued expenses (565,901) (260,275)
Other liabilities 140,106 94,598
Net cash provided by (used in) operating activities (1,331,824) (397,209)
Cash flows from investing activities:    
Acquisition of property, plant and equipment (357,570) (346,092)
Proceeds from disposition of property, plant and equipment 8,181 7,708
Expenditures for major repairs (45,732) (10,659)
Proceeds from Sale of Other Investments 508,415 0
Changes in CHS Capital notes receivable, net 88,682 174,858
Payments to Acquire Businesses, Net of Cash Acquired (236,461) 0
Other investing activities, net (11,398) (11,169)
Net cash provided by (used in) investing activities (45,883) (185,354)
Cash flows from financing activities:    
Proceeds from lines of credit and long-term borrowings 7,571,556 1,885,088
Payments on lines of credit, long-term borrowings and capital lease obligations (6,207,861) (2,025,935)
Preferred stock dividends paid (84,334) (84,334)
Redemptions of equities (16,327) (16,458)
Cash patronage dividends paid (229,470) (300,750)
Other financing activities, net (1,385) (7,556)
Net cash provided by (used in) financing activities 1,032,179 (549,945)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (600) (2,780)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (346,128) (1,135,288)
Cash and cash equivalents and restricted cash at beginning of period 873,862 1,844,587
Cash and cash equivalents and restricted cash at end of period $ 527,734 $ 709,299